These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC, Ozawa M. Clin Transpl; 2007 Apr 15; ():219-26. PubMed ID: 18642453 [Abstract] [Full Text] [Related]
3. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Tambur AR, Bray RA, Takemoto SK, Mancini M, Costanzo MR, Kobashigawa JA, D'Amico CL, Kanter KR, Berg A, Vega JD, Smith AL, Roggero AL, Ortegel JW, Wilmoth-Hosey L, Cecka JM, Gebel HM. Transplantation; 2000 Oct 15; 70(7):1055-9. PubMed ID: 11045642 [Abstract] [Full Text] [Related]
4. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. Karpinski M, Rush D, Jeffery J, Exner M, Regele H, Dancea S, Pochinco D, Birk P, Nickerson P. J Am Soc Nephrol; 2001 Dec 15; 12(12):2807-2814. PubMed ID: 11729251 [Abstract] [Full Text] [Related]
5. Multilaboratory evaluation of serum analysis for HLA antibody and crossmatch reactivity by lymphocytotoxicity methods. Duquesnoy RJ, Marrari M. Arch Pathol Lab Med; 2003 Feb 15; 127(2):149-56. PubMed ID: 12562227 [Abstract] [Full Text] [Related]
6. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation. Abdel Rahman AS, Fahim NM, El Sayed AA, El Hady SA, Ahmad YS. Egypt J Immunol; 2005 Feb 15; 12(2):77-89. PubMed ID: 17977213 [Abstract] [Full Text] [Related]
8. The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients. Kolonko A, Bzoma B, Giza P, Styrc B, Sobolewski M, Chudek J, Dębska-Ślizień A, Więcek A. Medicina (Kaunas); 2018 Sep 20; 54(5):. PubMed ID: 30344297 [Abstract] [Full Text] [Related]
14. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Wahrmann M, Exner M, Haidbauer B, Schillinger M, Regele H, Körmöczi G, Böhmig GA. Hum Immunol; 2005 May 20; 66(5):526-34. PubMed ID: 15935890 [Abstract] [Full Text] [Related]
15. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients. Lieber SR, Perez FV, Tabossi MR, Persoli LB, Marques SB, Mazzali M, Alves-Filho G, de Souza CA. Transplant Proc; 2007 Mar 20; 39(2):429-31. PubMed ID: 17362748 [Abstract] [Full Text] [Related]
17. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity. Thammanichanond D, Athimang W, Paisooksantivatana K, Mongkolsuk T, Ingsathit A, Worawichawong S, Kitpoka P, Jirasiritham S, Kantachuvesiri S. Transplant Proc; 2012 Jan 20; 44(1):62-5. PubMed ID: 22310580 [Abstract] [Full Text] [Related]
18. Long-term kidney graft survival across a positive historic but negative current sensitized cross-match. Baron C, Pastural M, Lang P, Bentabet R, el-Kassar N, Seror T, Dahmane D, Desvaux D, Chopin D, Fruchaud G, Remy P, Grimbert P, Lepage E, Bierling P. Transplantation; 2002 Jan 27; 73(2):232-6. PubMed ID: 11821736 [Abstract] [Full Text] [Related]
19. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL. Transplantation; 2002 Sep 27; 74(6):799-804. PubMed ID: 12364858 [Abstract] [Full Text] [Related]
20. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history? Tafulo S, Osório E, Mendes C, Liwski R. Hum Immunol; 2024 Jan 27; 85(1):110734. PubMed ID: 38030522 [Abstract] [Full Text] [Related] Page: [Next] [New Search]